corona vaccine antibody in odisha: in odisha antibodies could not be made in 20% of the people who took both the doses of the vaccine

In Odisha, about 20 percent of the people who have taken both the doses of the vaccine being applied to protect against the corona virus have not been able to make antibodies. These people may need a booster dose. The Bhubaneswar-based Institute of Life Sciences (ILS) has reported that 20 percent of people have not made antibodies against SARS-CoV2.

ILS Director Dr. Ajay Parida informed that so far more than 61.32 lakh people in Odisha have taken both the doses of anti-Covid-19 vaccine. Of these, more than one million people are in Bhubaneswar and about 20 percent of them have not developed antibodies against SARS-CoV2. They may need a booster dose. The ILS director said, ‘Although some patients infected with Kovid-19 have an antibody level of 30,000 to 40,000, it is less than 50 in some people who have received the vaccine. If the antibody level is 60 to 100 then we can say that the person is antibody positive.

‘Vaccine effectiveness only 70 to 80 percent’
Dr. Ajay Parida said that the effectiveness of Covishield and Covaccine vaccines is only 70 to 80 percent. Not being able to make antibodies despite taking two doses of the anti-Covid-19 vaccine may be due to individual differences in the genetic sequence. “This fact was revealed through antibody genome sequencing study,” he said. Dr. Parida said that apart from children and adolescents in the age group of 0 to 18 years, these 20 percent of adults who have received both doses of the vaccine are also vulnerable to the infection of Kovid-19. They need to be extra careful during a possible third wave of the pandemic. ILS, Bhubaneswar, is part of the Indian SARS-CoV2 Genome Consortium, a network of 28 laboratories spread across the country.

Leave a Comment